Search results
Senseonics gets FDA clearance to pair CGM implant with insulin pumps
MedTech Dive via Yahoo Finance· 19 hours agoDive Brief: Senseonics has received an integrated continuous glucose monitoring (iCGM) designation...
Stock Market Crash Alert: 3 Must-Buy Healthcare Stocks When Prices Plunge
InvestorPlace· 2 hours agoHealthcare stocks certainly haven’t set the world on fire lately. The S&P Health Care Index is up 3%...
Galaxy Watch 7 rumor puts blood sugar monitoring back on the table
Android Central· 5 days agoA report suggests Samsung may implement blood sugar monitoring capabilities on the Galaxy Watch 7...
Glutality powered by StrideMD Announces Integration with Dexcom to Enhance Remote Diabetes Care with...
FOX 59 Indianapolis· 1 day agoGlutality is compatible with the Dexcom G6 and Dexcom G7 CGM systems, which provide personalized, actionable glucose insights for people with diabetes and their care teams ...
FDA Allows Implantable CGM to Integrate With Insulin Pumps
Medscape· 17 hours agoThe US Food and Drug Administration grants new status to Sensionics' Eversense
2 Beaten-Down Dividend Stocks to Buy and Hold Forever
Motley Fool via Yahoo Finance· 3 days agoAbbott Laboratories offers many essential products. Some of its better-known devices still have...
DexCom (DXCM) Q1 Earnings Beat, Strong CGM Demand Continues
Zacks via Yahoo Finance· 5 days agoDexCom's (DXCM) first-quarter 2024 results reflect strong domestic and international revenue growth...
Drew Sycoff Purchases 182,540 Shares of GlucoTrack, Inc. (NASDAQ:GCTK) Stock
ETF DAILY NEWS· 6 days agoGlucoTrack, Inc. (NASDAQ:GCTK – Get Free Report) Director Drew Sycoff acquired 182,540 shares of the company’s stock in a transaction dated Monday, April 22nd. The shares were purchased at an ...
What if I can't find a doctor? Physician shortage will change how Americans receive care.
USA TODAY Opinion via Yahoo News· 12 hours agoOpinion alerts: Get columns from your favorite columnists + expert analysis on top issues, delivered...
Type 1 Diabetes Market Expected to Reach USD 13.64 Billion by 2030 Predicts SNS Insider | Leading...
Digital Journal· 5 days agoThe global Type 1 Diabetes Market, which was valued at USD 7.59 billion in 2022, is anticipated to...